Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 5, 2021
- Accepted June 25, 2021
- Published online July 15, 2021.
Article Versions
- You are currently viewing a previous version of this article (July 15, 2021 - 07:52).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Frédéric Becq1,
- Sandra Mirval1,
- Thomas Carrez1,2,
- Manuella Lévêque1,
- Arnaud Billet1,
- Christelle Coraux3,
- Edouard Sage4,5 and
- Anne Cantereau1
- 1Laboratoire Signalisation et Transports Ioniques Membranaires, Université de Poitiers, France
- 2ManRos therapeutics, Presqu’île de Perharidy, Roscoff, France
- 3INSERM UMR-S 1250, Université de Reims-Champagne Ardenne, Reims, France
- 4INRAE UMR 0892, Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France
- 5Service de chirurgie thoracique et transplantation pulmonaire, Hôpital Foch, Suresnes, France
- Corresponding author: Frederic Becq (frederic.becq{at}univ-poitiers.fr)
Funding
Association Vaincre la Mucoviscidose
RF20200502704Cystic Fibrosis Trust
SRC005
Article usage
Altmetrics
Vol 59 Issue 5
Table of Contents
The rescue of F508del-CFTR by elexacaftor/tezacaftor/ivacaftor (Trikafta) in human airway epithelial cells is underestimated due to the presence of ivacaftor
